Главная › Немелкоклеточный рак легкого › Калифорния › San Diego
Клинические исследования Немелкоклеточный рак легкого в городе San Diego, CA
48 исследований по теме Немелкоклеточный рак легкого ищут участников в центрах в городе San Diego и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Набор участниковФаза 2/3
- UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla · 11 миль отсюда
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набор участниковФаза 3
- Kaiser Permanente-San Diego Zion, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Набор участниковФаза 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 миль отсюда
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набор участниковФаза 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Набор участниковФаза 3
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Набор участниковФаза 1
- University of California San Diego Moores Cancer Center, San Diego
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Набор участниковФаза 1
- ALX Center 9, La Jolla · 11 миль отсюда
A Study of PHN-012 in Patients With Advanced Solid Tumors
Набор участниковФаза 1
- PHN-012-001 Site, San Diego
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Набор участниковФаза 2
- University of California at San Diego, La Jolla · 11 миль отсюда
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Набор участниковФаза 3
- UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
- UC San Diego Medical Center - Hillcrest, San Diego
- UCSD Medical Center - Rancho Bernardo, San Diego
- и еще 3
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Набор участниковНаблюдательное исследование
- University of California San Diego, La Jolla · 11 миль отсюда
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Moores Cancer Center at UC San Diego Health, La Jolla · 11 миль отсюда
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- University of California San Diego Health, La Jolla · 11 миль отсюда
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Набор участниковФаза 1/2
- Scripps Clinic Torrey Pines (Scripps Cancer Center), La Jolla · 11 миль отсюда
- Scripps Green Hospital, La Jolla · 11 миль отсюда
- Scripps Shiley Pavilion, La Jolla · 11 миль отсюда
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Набор участниковФаза 3
- Kaiser Permanente San Diego Mission Road, San Diego
Pan-tumor MRD Study
Набор участниковНаблюдательное исследование
- Medical Oncology Associates of San Diego (MOASD), San Diego
- Medical Oncology Associates of San Diego, San Diego
Intratumoral N17350 in Advanced Solid Tumors
Набор участниковФаза 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Набор участниковФаза 2/3
- University Of California - San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Набор участниковФаза 3
- Clinical Study Site, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Набор участниковНаблюдательное исследование
- University of California, San Diego, La Jolla · 11 миль отсюда
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Набор участниковФаза 1
- UCSD Moores Cancer Center, La Jolla · 11 миль отсюда
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Набор участниковФаза 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 миль отсюда
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Набор участниковФаза 3
- Research Site, San Diego
- Research Site, La Jolla · 11 миль отсюда
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Набор участниковФаза 1
- University of California - San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Набор участниковФаза 3
- Sharp Memorial Hospital ( Site 9544), San Diego
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Набор участниковФаза 1
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Набор участниковФаза 1
- University of California San Diego, Moores Cancer Center, San Diego
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Набор участниковФаза 3
- Research Site, San Diego
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Набор участниковФаза 2
- Kaiser Permanente San Diego Mission Road, San Diego
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Набор участниковФаза 3
- UC San Diego Medical Center - Hillcrest, San Diego
- California Protons Cancer Therapy Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Набор участниковФаза 1/2
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Набор участниковФаза 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Набор участниковФаза 1/2
- University of California, San Diego Moores Cancer Center, San Diego
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Набор участниковФаза 1/2
- UCSD Moores Cancer Center, La Jolla · 11 миль отсюда
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набор участниковФаза 2
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Набор участниковФаза 1
- University of California San Diego Moores Cancer Center, San Diego
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Набор участниковФаза 3
- Research Site, San Diego
- Research Site, La Jolla · 11 миль отсюда
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Набор участниковФаза 2
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набор участниковФаза 2/3
- Kaiser Permanente-San Diego Zion, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набор участниковФаза 2
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Набор участниковФаза 2
- University of California San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Набор участниковФаза 1/2
- University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla · 11 миль отсюда
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Набор участниковФаза 1/2
- Research Site, La Jolla · 11 миль отсюда
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Набор участниковФаза 1/2
- VA San Diego Healthcare System, San Diego, CA, San Diego
Retifanlimab and Ruxolitinib In Solid Malignancies
Набор участниковФаза 1/2
- University of California, San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, La Jolla · 11 миль отсюда
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Набор участниковФаза 1/2
- UCSD Moores Cancer Center, La Jolla · 11 миль отсюда
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Набор участниковФаза 1
- UC San Diego Moores Cancer Center, La Jolla · 11 миль отсюда
Исследования Немелкоклеточный рак легкого в других городах
- Houston, TX145 исследований
- New York City, NY121 исследование
- Arlington, VA104 исследований
- Nashville, TN97 исследований
- Boston, MA90 исследований
- Los Angeles, CA87 исследований
- St. Louis, MO73 исследований
- Chicago, IL61 исследование
- Baltimore, MD60 исследований
- San Antonio, TX59 исследований
- Columbus, OH57 исследований
- Washington, DC55 исследований
Другие исследования в городе San Diego
- Рак молочной железы41 исследование
- Рак (все виды)32 исследований
- Рак простаты31 исследование
- Метастатический рак30 исследований
- Колоректальный рак25 исследований
- Рак яичников24 исследований
- Рак поджелудочной железы24 исследований
- Рак легких23 исследований
- Ожирение23 исследований
- Сердечная недостаточность23 исследований
- Депрессия21 исследование
- Меланома18 исследований
Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.